Dr. Ian Pitcher presented the TTM2 Trial, which is an open-label trial with blinded assessment of outcomes comparing targeted hypothermia at 33°C, followed by controlled rewarming to targeted normothermia with…
Read More
Dr. Nav Malhi presented the RHAPSODY Trial, which is a phase 3, multicenter, double-blind, event-driven, randomized-withdrawal trial of rilonacept in patients with acute symptoms of recurrent pericarditis and systemic inflammation.…
Read More
Dr. Madeleine Barker presented the Two Years Outcomes of PARTNER 3, which is a randomized controlled clinical trial looking at transcatheter valve replacement (TAVR) in patients with symptomatic severe aortic stenosis and low surgical risk…
Read More
